Gonzalez Marcos R, Castillo-Flores Samy, Portmann-Baracco Arianna, Pretell-Mazzini Juan
Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Perú.
Miami Cancer Institute, Division of Orthopedic Oncology, Baptist Health System South Florida, Plantation, FL, USA.
HSS J. 2024 Nov;20(4):556-566. doi: 10.1177/15563316231172510. Epub 2023 May 21.
Proximal tibiofibular joint (PTFJ) ganglion cyst is a rare condition with a high rate of recurrence. Optimal treatment has not yet been determined. : We aimed to answer the following questions: (1) What are the most common treatments for PTFJ cysts and their associated recurrence rates? (2) What are the risk factors for failure to completely recover from symptoms? (3) What are the risk factors for cyst recurrence? : A systematic review was performed using PubMed and EMBASE databases. Studies were assessed for inclusion and exclusion criteria, and quality analysis following the PRISMA guidelines. Information on demographic, clinical, and treatment characteristics was retrieved from articles. : The most common surgical treatment was cyst excision (75.3%). Patients with PTFJ arthrodesis and PTFJ resection had the lowest recurrence rates at 0% and 4.4%, respectively. Complete recovery from symptoms was more common in PTFJ resection (70.8%) than in PTFJ arthrodesis (42.9%). Risk factors for failure to achieve complete recovery from symptoms included intraneural compromise (odds ratio [OR] = 3.93), cyst recurrence (OR = 6.04), and being a contact sports athlete (OR = 9.85). Ligation of the articular branch of the peroneal nerve (PN) was a protective factor (OR = 0.29). A history of knee arthritis was the most important risk factor for cyst recurrence (OR = 20.01); PTFJ arthrodesis was a protective factor (OR = 0.04). : This systematic review of level-IV studies found PTFJ resection or arthrodesis to be the most effective treatment options. Intraneural compromise of the common peroneal nerve, cyst recurrence, and participation in contact sports are risk factors for incomplete symptom recovery, and ligation of the articular branch of the PN is a protective factor. Knee arthritis is a risk factor for cyst recurrence. More rigorous study is needed.
近端胫腓关节(PTFJ)腱鞘囊肿是一种罕见疾病,复发率高。目前尚未确定最佳治疗方法。我们旨在回答以下问题:(1)PTFJ囊肿最常见的治疗方法及其相关复发率是多少?(2)症状未能完全恢复的危险因素有哪些?(3)囊肿复发的危险因素有哪些?使用PubMed和EMBASE数据库进行了系统评价。根据PRISMA指南对研究进行纳入和排除标准评估以及质量分析。从文章中检索人口统计学、临床和治疗特征方面的信息。最常见的手术治疗是囊肿切除术(75.3%)。接受PTFJ关节融合术和PTFJ切除术的患者复发率最低,分别为0%和4.4%。PTFJ切除术患者(70.8%)症状完全恢复的情况比PTFJ关节融合术患者(42.9%)更常见。症状未能完全恢复的危险因素包括神经内受压(比值比[OR]=3.93)、囊肿复发(OR=6.04)以及从事接触性运动的运动员(OR=9.85)。腓总神经(PN)关节支结扎是一个保护因素(OR=0.29)。膝关节关节炎病史是囊肿复发的最重要危险因素(OR=20.01);PTFJ关节融合术是一个保护因素(OR=0.04)。这项对IV级研究的系统评价发现,PTFJ切除术或关节融合术是最有效的治疗选择。腓总神经神经内受压、囊肿复发以及参与接触性运动是症状恢复不完全的危险因素,PN关节支结扎是一个保护因素。膝关节关节炎是囊肿复发的危险因素。需要更严格的研究。